This week, a displaced contact lens goes undetected for 28 years, a palm-sized imager lays bare individual photoreceptors and scientists unveil an ultrathin prosthesis that hugs the retina’s natural curves. Source: AAO
Following a priority review, the FDA has cleared cenergermin (Oxervate), a first-in-class treatment for moderate or severe neurotrophic keratitis. Source: AAO
This study analyzes the visual outcomes and rate of intraoperative complications of phacoemulsification surgery after prior pars plana vitrectomy. Source: AAO
This mouse study explored whether etanercept, a tumor necrosis factor inhibitor, can protect retinal ganglion cells and improve visual outcomes after optic nerve trauma. Source: AAO
This cross-sectional study compares the use of standard OCT with OCT angiography (OCT-A) for evaluating patients with glaucoma. Source: AAO
DeepMind plans to unleash an artificial intelligence product capable of diagnosing 50 ophthalmic conditions from a simple OCT scan, the company reports. Source: AAO
This cluster-randomized, intervention-controlled study examined the effect of a school-based program encouraging outdoor activities on myopia. Source: AAO
Sun Pharmaceuticals announced the approval of their preservative-free nanomicellar formulation of cyclosporine A for increasing tear production in patients with dry eye disease. Source: AAO
This week, retinal thinning heralds the onset of Parkinson’s disease, a piezo-print technology dots the cornea with a miniscule amount of latanoprost and sheep with achromatopsia wake up to good news about the benefits of CNGA3 gene therapy. Source: AAO
This study compares the efficacy and safety of intravitreous ranibizumab versus panretinal photocoagulation over 5 years of treatment in patients with proliferative diabetic retinopathy. Source: AAO
Tel: 518-580-0553
Get Directions »
Tel: 518-580-0553
Get Directions »
Tel: +1 (518) 580-0553
Get Directions »
